French investment firm ArchiMed agreed to acquire Natus Medical (Nasdaq: NUTUS) for approximately $1.2 billion, taking the Middleton, Wisconsin-based medical device company private.
Why it matters: Operating as a private company arguably gives Natus an opportunity to better steer its offerings — which span neurological, audiology and infant diagnostics and monitoring— toward higher-growth areas.
